CN Patent

CN102105140B — 涂覆片剂的方法

Assigned to BASF SE · Expires 2013-10-23 · 13y expired

What this patent protects

本发明涉及一种用于涂覆固体基质(S)的聚合物组合物，其包含：a)0.5～90重量％重均分子量为1,500～20,000g/mol的聚乙二醇(组分A)，b)0.5～20重量％Fikentscher K值为12～90的水溶性聚乙烯吡咯烷酮(组分B)，c)0～95重量％溶剂(L)，和d)0～70重量％一种或多种非聚合物助剂(组分C)。

USPTO Abstract

本发明涉及一种用于涂覆固体基质(S)的聚合物组合物，其包含：a)0.5～90重量％重均分子量为1,500～20,000g/mol的聚乙二醇(组分A)，b)0.5～20重量％Fikentscher K值为12～90的水溶性聚乙烯吡咯烷酮(组分B)，c)0～95重量％溶剂(L)，和d)0～70重量％一种或多种非聚合物助剂(组分C)。

Drugs covered by this patent

bupropion-hydrobromide (BUPROPION HYDROBROMIDE)

Patent Metadata

Patent number: CN102105140B
Jurisdiction: CN
Classification: —
Expires: 2013-10-23
Drug substance claim: No
Drug product claim: No
Assignee: BASF SE
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.